II. Causes: General
- Most common causes of Hypercalcemia
- Malignancy
- Primary Hyperparathyroidism
- Malignancy
- See Hypercalcemia of Malignancy (mediated by PTH-Related peptide)
- Presents with rapid onset, low PTH Levels and weight loss, Night Sweats
- Breast Cancer with bone metastases
- Squamous Cell Lung Cancer
- Head and Neck squamous cell cancer
- Renal Cell Cancer
- Esophageal Cancer
- Skin Cancer
- Hematologic
- Paget's Disease of Bone
- Medications
- Thiazide Diuretics
- Lithium
- Vitamin A Toxicity
- Vitamin D Toxicity (e.g. 25-Hydroxyvitamin D2)
- Milk Alkali Syndrome
- Theophylline
- Synthetic PTH (Teriparatide, Abaloparatide)
-
Hyperparathyroidism (PTH Dependent Hyperparathyroidism)
- Primary Hyperparathyroidism (most common cause)
- Multiple Endocrine Neoplasia (type 1 or 2A)
- Familial Hypocalciuric Hypercalcemia
- Lithium treatment
- Chronic Kidney Disease (Renal Osteodystrophy)
- Hyperparathyroidism - Jaw Tumor Syndrome
- Endocrine
- Other causes
- Familial Hypocalciuric Hypercalcemia
- Prolonged immobilization
- Granulomatous disease (Sarcoidosis, Tuberculosis, Histoplasmosis, Coccidioidomycosis)
- Williams Syndrome
- Jansen Disease (metaphyseal chondrodysplasia)
III. Findings: Symptoms and Signs
- Often asymptomatic
- Symptoms and Signs are related to Serum Calcium Levels
- Calcium > 11.5 mg/dl (2.9 mmol/L)
- Symptom onset
- Calcium > 13 mg/dl (3.2 mmol/L)
- Nephrocalcinosis
- Acute Renal Failure
- Calcium >14 mg/dl (3.5 mmol/L)
- Severe Hypercalcemia (or Parathyroid crisis)
- Calcium > 11.5 mg/dl (2.9 mmol/L)
- Cardiovascular
- Gastrointestinal
- Renal
- Polydipsia
- Polyuria
- Renal Colic or Flank Pain
- Renal Failure
- Neurologic
- Anxiety
- Confusion, Delirium
- Decreased Concentration
- Memory Loss
- Headache
- Fatigue
- Lethargy
- Weakness
- Psychiatric
- Anxiety
- Depressed Mood
- Emotional lability
- Musculoskeletal
- Bone pain
- Arthralgias
- Myalgias
- Pathologic Fractures
- Skin
- Pruritus (Metastatic calcification of skin)
IV. Complications: Stones, Bones, Moans, Psychic Groans
- Renal ("Stones")
- Nephrolithiasis (Calcium Oxalate)
- Nephrocalcinosis
- Metastatic calcification renal tubules
- Polyuria from loss of urine concentrating function
- Musculoskeletal ("Bones")
- Osteitis fibrosa cystica (Late finding)
- Bone cysts from subperiosteal bone resorption
- "Brown tumor" in jaw
- Pseudogout
- Calcium pyrophosphate - Positively birefringent
- Osteoporosis
- Osteitis fibrosa cystica (Late finding)
- Gastrointestinal ("Abdominal Moans")
- Peptic Ulcer Disease
- Acute Pancreatitis
- Calcium activates phospholipases
- Constipation
- Most common gastrointestinal symptom
- Neuropsychiatric ("Psychic groans")
- Altered Level of Consciousness or Delirium
- Decreased concentration and memory
- Personality change
- Psychosis
- Major Depression
- Eye
- Band Keratopathy (Corneal calcification)
- Metastatic calcification in eye limbus
- Band Keratopathy (Corneal calcification)
- Cardiovascular
- Cardiac Arrhythmia
- Diastolic Dysfunction
- Hypertension
- Hypercalcemia Vasoconstricts vessels
V. Imaging
- Calcified soft tissues
VI. Labs: Serum Calcium
- Total Serum Calcium increased
- Hypercalcemia: Total Serum Calcium > 10.5 mg/dl
- Severe Hypercalcemia (Hypercalcemic Crisis): Serum Calcium >14 mg/dl (>3.50 mmol/L)
- Confirmatory
- Ionized Calcium >5.6 mg/dl or
- Corrected Serum Calcium increased (corrected for Serum Albumin)
VII. Labs: Hypercalcemia Evaluation
- First-line
- Parathyroid Hormone
- 25-Hydroxyvitamin D
- Serum Magnesium
- Serum Creatinine
- Second-line: PTH level normal or high (PTH-dependent Hypercalcemia)
- Urine Calcium to Creatinine Ratio
- Decreased <0.01 in Familial Hypocalciuric Hypercalcemia
- Increased >0.01 in Primary Hyperparathyroidism, Hypercalcemia or Malignancy, MEN I
- Urine Calcium to Creatinine Ratio
- Second-line: PTH level <20 pg/ml (PTH-independent Hypercalcemia)
- Parathyroid Hormone-related Peptide (PTHrp) increased
- Hypercalcemia of Malignancy
- Consider broad evaluation for malignancy
- Complete Blood Count
- Liver Function Tests
- Chest XRay
- Chest CT and Abdominal CT
- Protein electrophoresis (SPEP and UPEP)
- Bone Scan
- Mammogram
- 1,25 Dihydroxyvitamin D increased
- Lymphoma
- Granuloma (e.g. Sarcoidosis)
- 25-Hydroxyvitamin D (Calcitriol) increased
- Parathyroid Hormone-related Peptide (PTHrp) increased
VIII. Diagnostics: Electrocardiogram
- Short QT Interval
- Prolonged PR Interval
- Wide QRS Complex
- Bradycardia
IX. Evaluation
-
General
- Primary Hyperparathyroidism and Hypercalcemia of Malignancy: 90% of cases
- Step 1: Confirm Hypercalcemia present (see labs above)
- Confirm Hypercalcemia with Ionized Calcium >5.6 mg/dl or Corrected Serum Calcium >10.5 mg/dl
- Immediate management for symptomatic or severe Hypercalcemia (Serum Calcium >14 mg/dl)
- See protocol below
- Step 2: Obtain history for potential causes
- See causes above
- Perform history (including diet, medications) and exam
- Consider Renal Osteodystrophy
- Eliminate potential causative medications (Thiazide Diuretics, Lithium)
- Step 3: Obtain intact Parathyroid Hormone (PTH) Level
- PTH low: Go to Step 4
- PTH normal or high (PTH-Dependent Hypercalcemia)
- Labs
- Urine Calcium to Creatinine Ratio (24 hour Urine Calcium and Urine Creatinine)
- Serum Creatinine
- Bone Mineral Density
- 25-Hydroxyvitamin D
- Urine Calcium to Creatinine Ratio <0.01
- Urine Calcium to Creatinine Ratio normal or high
- Causes
- Primary Hyperparathyroidism
- Recovery from Acute Tubular Necrosis
- Lithium
- Multiple Endocrine Neoplasia Type I (MEN I)
- Parathyroid carcinoma (severe Hypercalcemia and very high PTH)
- Approach
- Consult Endocrinology
- Exclude Multiple Endocrine Neoplasia Type I (MEN I)
- Manage Primary Hyperparathyroidism
- Medical management of Primary Hyperparathyroidism
- Parathyroidectomy if symptomatic, age <50, complications (e.g. renal)
- Causes
- Labs
- Step 4: PTH-Independent Hypercalcemia
- Assess for malignancy and endocrinopathy
- Careful history and examination for tumor
- Initial Labs
- Parathyroid Hormone-related Peptide (PTHrp)
- Increased in solid tumors (see Hypercalcemia of Malignancy)
- Consider broad evaluation for malignancy
- Complete Blood Count
- Liver Function Tests
- Chest XRay
- Chest CT and Abdominal CT
- Protein electrophoresis (SPEP and UPEP)
- Bone Scan
- Mammogram
- 1,25-dihydroxyvitamin D (Calcitriol) increased
- Obtain chest imaging (Chest XRay or Chest CT)
- Causes
- Lymphoma
- Granulomatous Disease (Sarcoidosis, Tuberculosis, Histoplasmosis, Coccidioidomycosis)
- 25-Hydroxyvitamin D Level increased
- Parathyroid Hormone-related Peptide (PTHrp)
- Other Labs to consider
- Alkaline Phosphatase: Increased with bone lysis
- Consider bone scan
- Protein electrophoresis (SPEP and UPEP)
- Monoclonal peak in Multiple Myeloma
- Endocrine Labs
- Thyroid Stimulating Hormone (Hyperthyroidism)
- Corticotropin Stimulation Test (Addison's Disease)
- Insulin-like Growth Factor 1 (Acromegaly)
- Alkaline Phosphatase: Increased with bone lysis
- Reconsider medication causes of low PTH
X. Management
- Identify and treat underlying cause
- Mild Hypercalcemia (Serum Calcium <12 mg/dl)
- Adequate Hydration (>2 Liters per day)
- Maximize mobility
- Diuretics if symptomatic
- Furosemide (Lasix) 40-160 mg/day
- Severe Hypercalcemia or Hypercalcemic Crisis (Serum Calcium >14 mg/dl, >3.50 mmol/L)
- Consider also in moderate symptomatic Hypercalcemia
- Normal Saline 2 to 4 Liters/day for 1-3 days
- Adjust to obtain 200 ml Urine Output per hour
- Exercise caution in Congestive Heart Failure
- Anticipate 1-3 mg/dl drop in Serum Calcium
- Additional measures if refractory after hydration
- Furosemide (Lasix) 10-20 mg every 1-2 hours as needed
- Most effective agent in Calcium elimination
- Calcitonin 4-8 IU/kg IM or SQ every 6 hours for 24 hours (up to 48 hours)
- Rapid onset, but weakest of the agents (do not use as monotherapy)
- Furosemide (Lasix) 10-20 mg every 1-2 hours as needed
- Agents with specific indications
- Malignancy: Bisphosphonates
- Zoledronic acid (Zometa) 4 mg IV over 15 minutes
- Pamidronate (Aredia) 60-90 mg IV over 4 hours
- Vitamin D Toxicity, Lymphoma, Myeloma or Granuloma
- Hydrocortisone 200 mg IV qd for 3 days
- Malignancy: Bisphosphonates
- Other measures
- Oral Phosphate (Neutra-Phos) 250 mg PO q6 hours
- Denosumab
- Third line agents due to toxicity (avoid if possible)
- Plicamycin 10-25 mcg/kg/day IV over 6 hours x3 dose
- Cumulative liver, Kidney and Platelet toxicity
- Bisphosphonates are preferred over Plicamycin
- Gallium Nitrate (Ganite)
- Dose: 100-200 mg/m2 IV over 24 hours for 5 days
- Significant renal and Bone Marrow toxicity
- Plicamycin 10-25 mcg/kg/day IV over 6 hours x3 dose
- Refractory Cases
XI. Prognosis
-
Hypercalcemia of Malignancy suggests terminal stages
- Implies Life Expectancy of days to weeks
XII. References
- Gibbs in Marx (2002) Rosen's Emergency Med, p. 1734-6
- Spiegel in Goldman (2000) Cecil Medicine, p. 1400-2
- Carroll (2003) Am Fam Physician 67(9):1959-66 [PubMed]
- Michels (2013) in Am Fam Physician 88(4): 249-57 [PubMed]
- Minisola (2015) BMJ 350: h2723 [PubMed]
- Sell (2022) Am Fam Physician 105(3): 289-98 [PubMed]
- Suliburk (2007) Oncologist 12(6): 644-53 [PubMed]
- Ziegler (2001) J Am Soc Nephrol 12 Suppl 17:S3-9 [PubMed]
Images: Related links to external sites (from Bing)
Related Studies
Definition (CHV) | high level of calcium in the blood |
Definition (CHV) | high level of calcium in the blood |
Definition (MSHCZE) | Abnormálně vysoká úroveň vápníku v krvi. |
Definition (NCI_NCI-GLOSS) | Higher than normal levels of calcium in the blood. Some types of cancer increase the risk of hypercalcemia. |
Definition (NCI) | Abnormally high concentration of calcium in the peripheral blood. |
Definition (NCI_CTCAE) | A disorder characterized by laboratory test results that indicate an elevation in the concentration of calcium in blood. |
Definition (MSH) | Abnormally high level of calcium in the blood. |
Definition (CSP) | abnormally high level of calcium in the blood; manifestations include fatigability, muscle weakness, depression, anorexia, nausea, and constipation. |
Concepts | Disease or Syndrome (T047) |
MSH | D006934 |
ICD9 | 275.42 |
ICD10 | E83.52 |
SnomedCT | 154752005, 267505006, 166702002, 66931009 |
English | Hypercalcemia, Hypercalcemias, HYPERCALCAEMIA, HYPERCALCEMIA, hypercalcemia, hypercalcemia (diagnosis), Blood calcium increased, Calcium blood increased, Hypercalcemia [Disease/Finding], Serum calcium concentration above normal, Hypercalcemic disorder, Hypercalcemia syndrome, Hypercalcaemia, Hypercalcaemia syndrome, Raised serum calcium level, Hypercalcemia (disorder), Raised serum calcium level (finding), hypercalcinemia, hypercalcaemia |
French | HYPERCALCEMIE, Calcium sanguin augmenté, Hypercalcémie |
Portuguese | HIPERCALCEMIA, Cálcio no sangue aumentado, Síndrome Leite-Álcalis, Síndrome do Leite e Alcalino, Calcemia aumentada, Hipercalcemia |
Spanish | HIPERCALCEMIA, hipercalcemia (trastorno), hipercalcemia, nivel elevado de calcio sérico (hallazgo), nivel elevado de calcio sérico, síndrome de hipercalcemia, síndrome hipercalcémico, Calcio elevado en sangre, Hipercalcemia |
German | HYPERKALZAEMIE, Hyperkalzaemie, Hyperkalziaemie, Kalzium im Blut erhoeht, Hyperkalzämie |
Dutch | calcium bloed verhoogd, bloed calcium verhoogd, hypercalciëmie, Burnett, syndroom van, Calciëmie, hyper-, Hypercalciëmie |
Japanese | 血中カルシウム増加, 高カルシウム血症, ケッチュウカルシウムゾウカ, コウカルシウムケツショウ, コウカルシウムケッショウ |
Swedish | Hyperkalcemi |
Finnish | Hyperkalsemia |
Russian | GIPERKAL'TSIEMIIA PISHCHEVAIA, SINDROM, MOLOCHNOGO ALKOGOLIKA SINDROM, BERNETTA SINDROM, GIPERKAL'TSIEMIIA, MOLOCHNO-SHCHELOCHNOI SINDROM, БЕРНЕТТА СИНДРОМ, ГИПЕРКАЛЬЦИЕМИЯ, ГИПЕРКАЛЬЦИЕМИЯ ПИЩЕВАЯ, СИНДРОМ, МОЛОЧНОГО АЛКОГОЛИКА СИНДРОМ, МОЛОЧНО-ЩЕЛОЧНОЙ СИНДРОМ |
Czech | Hyperkalcemie, Zvýšený vápník v krvi, Kalcium v krvi zvýšené, hyperkalcémie, hyperkalcemie |
Croatian | HIPERKALCEMIJA |
Italian | Calcio ematico aumentato, Ipercalcemia |
Polish | Hiperkalcemia, Zespół mleczno-alkaliczny |
Hungarian | Kalcium vérszint emelkedett, Hypercalcaemia |
Norwegian | Hyperkalcemi, Hyperkalsemi |